Brainlab company is pleased to announce that their Vascular Navigation PAD software used for mobile C-arms has received FDA 510(k) clearance for the US market
This advancement allows for the treatment of peripheral artery disease (PAD) with reduction in radiation and contrast agent, enhancing safety for physicians and patients.





